Efficacy of Drakshapathyadi Syrup versus Levosalbutamol Syrup in the Management of Tamak Shwasa in Children: A Comparative Study

COMPARATIVE EXPLORATORY STUDY ON DRAKSHAPATHYADI SYRUP AND LEVO SALBUTAMOL SYRUP IN THE MANAGEMENT OF TAMAK SHWASA JUVENILE BRONCHIAL ASTHMA IN CHILDREN - NIL

Status

Active, not recruiting

Phases

Phase 3Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/04/108998

Enrollment

Registered

2026-04-21

Start date

Unknown

Completion date

Unknown

Last updated

2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J459- Other and unspecified asthma

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Individual between age group of 05 to 18 years of both sexes Patients having classical features of Tamak Shwasa as described in classical textbooks

Exclusion criteria

Exclusion criteria: Child below 05 year & above 18 years of age will be excluded from present study Patients suffering from chronic respiratory disorders like pulmonary tuberculosis chronic lung disease pulmonary edema bronchogenic carcinoma will be excluded from present study Patient suffering from cardiac disease GIT disease genitourinary disease metabolic disorders like diabetes mellitus and behavioral disorders etc. will be excluded from study Congenital anomalies of the respiratory tract or congenital heart disease

Design outcomes

Primary

Measure	Time frame
To compare the efficacy of Drakshapathyadi syrup an Ayurvedic formulation and Levosalbutamol syrup a standard bronchodilator in the management of Tamak Shwasa (Juvenile Bronchial Asthma) in childrenTimepoint: 30 days	—

Secondary

Measure	Time frame
To evaluate the effect of Drakshapathyadi syrup and Levosalbutamol syrup on clinical symptoms of Tamak Shwasa including dyspnea wheezing cough and chest tightness To assess changes in pulmonary function parameters (such as PEFR and FEV1) in children receiving either treatment To determine the safety and tolerability of Drakshapathyadi syrup in comparison with Levosalbutamol syrup in the pediatric population To observe the effect of both interventions on the frequency and severity of asthma exacerbations during the study period To explore the impact of Drakshapathyadi syrup on overall quality of life in children with juvenile bronchial asthma compared to standard therapy.Timepoint: 30 days	—

Measure

Time frame

To evaluate the effect of Drakshapathyadi syrup and Levosalbutamol syrup on clinical symptoms of Tamak Shwasa including dyspnea wheezing cough and chest tightness To assess changes in pulmonary function parameters (such as PEFR and FEV1) in children receiving either treatment To determine the safety and tolerability of Drakshapathyadi syrup in comparison with Levosalbutamol syrup in the pediatric population To observe the effect of both interventions on the frequency and severity of asthma exacerbations during the study period To explore the impact of Drakshapathyadi syrup on overall quality of life in children with juvenile bronchial asthma compared to standard therapy.Timepoint: 30 days

—

Countries

India

Contacts

Public ContactProf Dr Harish Kumar Singhal

Post Graduate Institute of Ayurveda JODHPUR

ayurharish14@gmail.com8619892143

Outcome results